Nevakar featured in Tech News

Dr. Puri's first venture, InnoPharma, was founded in 2005 with a focus on developing complex generic pharmaceuticals of sterile injectable dose forms. This was sold to Pfizer in 2014. Puri went on to found Nevakar, which is a specialty pharmaceutical company, focused...

Nevakar Featured in Global Business Reports

You previously had great success with InnoPharma, which was eventually sold to Pfizer. Could you provide some insight into your new venture, Nevakar? InnoPharma's acquisition was a strategic move by Pfizer; its product pipeline and track record of successfully...